{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:12:09Z","timestamp":1791306729365,"version":"4.3.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,5]],"date-time":"2016-11-05T00:00:00Z","timestamp":1478304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijpddr.2016.12.004","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T09:04:03Z","timestamp":1482483843000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["In\u00a0vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi"],"prefix":"10.1016","volume":"7","author":[{"given":"Adriana","family":"Botero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Keatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Peacock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C. Andrew","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2016.12.004_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: medecins Sans Frontieres experience in the Democratic Republic of the Congo","volume":"56","author":"Alirol","year":"2013","journal-title":"Clin. Infect. Dis. official Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib2","doi-asserted-by":"crossref","first-page":"e3259","DOI":"10.1371\/journal.pntd.0003259","article-title":"High throughput screening for anti-Trypanosoma cruzi drug discovery","volume":"8","author":"Alonso-Padilla","year":"2014","journal-title":"PLoS neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib3","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0022-1759(94)90396-4","article-title":"A\u00a0new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H] thymidine incorporation assay","volume":"170","author":"Ansar Ahmed","year":"1994","journal-title":"J.\u00a0Immunol. methods"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1017\/S0031182009005927","article-title":"Morphological and molecular characterization of Trypanosoma copemani n. sp. (Trypanosomatidae) isolated from Gilbert's potoroo (Potorous gilbertii) and quokka (Setonix brachyurus)","volume":"136","author":"Austen","year":"2009","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1742-7843.2005.pto960109.x","article-title":"Leishmanicidal activity of edelfosine, miltefosine and ilmofosine","volume":"96","author":"Azzouz","year":"2005","journal-title":"Basic & Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2307\/3283170","article-title":"The lesions and prevalence of Trypanosoma cruzi in opossums and armadillos from southern Louisiana","author":"Barr","year":"1991","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib7","doi-asserted-by":"crossref","first-page":"e22155","DOI":"10.1371\/journal.pone.0022155","article-title":"Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in\u00a0vivo","volume":"6","author":"Batista","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.protis.2015.11.002","article-title":"Towards a better understanding of the life cycle of Trypanosoma copemani","volume":"167","author":"Botero","year":"2016","journal-title":"Protist"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijppaw.2013.03.001","article-title":"Trypanosomes genetic diversity, polyparasitism and the population decline of the critically endangered Australian marsupial, the brush tailed bettong or woylie (Bettongia penicillata)","volume":"2","author":"Botero","year":"2013","journal-title":"Int. J. Parasitol. Parasites Wildl."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpddr.2012.02.002","article-title":"Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis","volume":"2","author":"Bowling","year":"2012","journal-title":"Int. J. Parasitology-Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molbiopara.2010.11.001","article-title":"Trypanosoma cruzi MSH2: functional analyses on different parasite strains provide evidences for a role on the oxidative stress response","volume":"176","author":"Campos","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/S0074-02761996000500012","article-title":"Histopathological study of experimental and natural infections by Trypanosoma cruzi in Didelphis marsupialis","volume":"91","author":"Carreira","year":"1996","journal-title":"Memorias do Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/jac\/38.6.1041","article-title":"The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei","volume":"38","author":"Croft","year":"1996","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib15","doi-asserted-by":"crossref","first-page":"e2367","DOI":"10.1371\/journal.pntd.0002367","article-title":"Benznidazole and posaconazole in experimental chagas disease: positive interaction in concomitant and sequential treatments","volume":"7","author":"de Figueiredo Diniz","year":"2013","journal-title":"PLoS neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-2952(00)00477-9","article-title":"Uptake and mode of action of drugs used against sleeping sickness","volume":"61","author":"Denise","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib17","first-page":"20","article-title":"Evaluation of trypanocidal drugs used for human African trypanosomosis against Trypanosoma lewisi","author":"Dethoua","year":"2013","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib18","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib19","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00292-12","article-title":"Optimal dosing of miltefosine in children and adults with visceral leishmaniasis","volume":"56","author":"Dorlo","year":"2012","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","article-title":"Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites","volume":"5","author":"Engel","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib21","first-page":"1429","article-title":"Early stage monitoring of miltefosine induced apoptosis in KB cells by multinuclear NMR spectroscopy","volume":"16","author":"Engelmann","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib22","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00436-008-0876-9","article-title":"The toxic effects of piperine against Trypanosoma cruzi: ultrastructural alterations and reversible blockage of cytokinesis in epimastigote forms","volume":"102","author":"Freire-de-Lima","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib23","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1007\/s00018-016-2173-6","article-title":"Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense","volume":"73","author":"Graf","year":"2016","journal-title":"Cell. Mol. life Sci. CMLS"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib24","doi-asserted-by":"crossref","first-page":"e2475","DOI":"10.1371\/journal.pntd.0002475","article-title":"Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol","volume":"7","author":"Graf","year":"2013","journal-title":"PLoS neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.tiv.2004.03.012","article-title":"Comparison of alamar blue and MTT assays for high through-put screening","volume":"18","author":"Hamid","year":"2004","journal-title":"Toxicol. in\u00a0vitro"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib26","doi-asserted-by":"crossref","first-page":"31602","DOI":"10.1074\/jbc.M113.497990","article-title":"Complexes of Trypanosoma cruzi sterol 14alpha-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity","volume":"288","author":"Hargrove","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib27","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/jac\/dks027","article-title":"Safety of benznidazole use in the treatment of chronic Chagas' disease","volume":"67","author":"Hasslocher-Moreno","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib28","first-page":"37","article-title":"Apoptotic effects of hexadecylphosphocholine on resistant and nonresistant cells monitored by NMR spectroscopy","volume":"34","author":"Henke","year":"1998","journal-title":"Drugs Today"},{"issue":"9","key":"10.1016\/j.ijpddr.2016.12.004_bib29","doi-asserted-by":"crossref","first-page":"e44640","DOI":"10.1371\/journal.pone.0044640","article-title":"Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay","volume":"7","author":"Ho","year":"2012","journal-title":"PloS one"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib30","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1371\/journal.pmed.0030355","article-title":"A\u00a0Gambian infant with fever and an unexpected blood film","volume":"3","author":"Howie","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib31","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin. Infect. Dis. official Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib32","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1021\/jm2015809","article-title":"Analogues of fenarimol are potent inhibitors of Trypanosoma cruzi and are efficacious in a murine model of Chagas disease","volume":"55","author":"Keenan","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib33","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.4155\/fmc.13.139","article-title":"Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruzi","volume":"5","author":"Keenan","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib34","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.bmc.2013.01.050","article-title":"Design, structure-activity relationship and in\u00a0vivo efficacy of piperazine analogues of fenarimol as inhibitors of Trypanosoma cruzi","volume":"21","author":"Keenan","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"24","key":"10.1016\/j.ijpddr.2016.12.004_bib35","doi-asserted-by":"crossref","first-page":"10158","DOI":"10.1021\/jm401610c","article-title":"Two analogues of fenarimol show curative activity in an experimental model of chagas disease","volume":"56","author":"Keenan","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib36","first-page":"335","article-title":"American trypanosomiasis","author":"Kirchhoff","year":"1996","journal-title":"Princ. Pract. Clin. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood.V90.2.562","article-title":"Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines","volume":"90","author":"K\u00f6nig","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0001-706X(96)00628-6","article-title":"Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies","volume":"64","author":"Konstantinov","year":"1997","journal-title":"Acta trop."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib39","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1007\/s00436-016-5195-y","article-title":"Deep-sequencing revealing mutation dynamics in the miltefosine transporter gene in Leishmania infantum selected for miltefosine resistance","volume":"115","author":"Laffitte","year":"2016","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib40","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2174\/156802611796575902","article-title":"Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis","volume":"11","author":"Lepesheva","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jac\/47.5.537","article-title":"Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in\u00a0vitro activity by the sterol biosynthesis inhibitor ketoconazole","volume":"47","author":"Lira","year":"2001","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7705\/biomedica.v29i3.15","article-title":"In\u00a0vitro susceptibility of Trypanosoma cruzi strains from Santander, Colombia, to hexadecylphosphocholine (miltefosine), nifurtimox and benznidazole","volume":"29","author":"Luna","year":"2009","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0031182010000971","article-title":"Novel trypanosome Trypanosoma gilletti sp. (Euglenozoa: Trypanosomatidae) and the extension of the host range of Trypanosoma copemani to include the koala (Phascolarctos cinereus)","volume":"138","author":"McInnes","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib44","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/0140-6736(92)92180-N","article-title":"Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness","volume":"340","author":"Milord","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib45","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/srep04703","article-title":"Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development","volume":"4","author":"Moraes","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1590\/S0074-02762011000400015","article-title":"The in\u00a0vitro leishmanicidal activity of hexadecylphosphocholine (miltefosine) against four medically relevant Leishmania species of Brazil","volume":"106","author":"Morais-Teixeira","year":"2011","journal-title":"Memorias do Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/AAC.01023-13","article-title":"Treatment failure and miltefosine susceptibility in dermal leishmaniasis caused by Leishmania subgenus Viannia species","volume":"58","author":"Obonaga","year":"2014","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib48","series-title":"First WHO Report on Neglected Tropical Diseases: Working to Overcome the Global Impact of Neglected Tropical Diseases","author":"Organization","year":"2010"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1071\/AM96019","article-title":"New evidence concerning the extinction of the endemic murid Rattus macleari Thomas, 1887 from Christmas Island, Indian Ocean","volume":"19","author":"Pickering","year":"1996","journal-title":"Aust. Mammal."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib50","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.01401-12","article-title":"Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease","volume":"57","author":"Pinazo","year":"2013","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib51","doi-asserted-by":"crossref","first-page":"e1463","DOI":"10.1371\/journal.pntd.0001463","article-title":"Genetic polymorphisms and drug susceptibility in four isolates of Leishmania tropica obtained from Canadian soldiers returning from Afghanistan","volume":"6","author":"Plourde","year":"2012","journal-title":"PLoS neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0001-706X(97)00079-X","article-title":"The Alamar Blue\u00ae assay to determine drug sensitivity of African trypanosomes (Tb rhodesiense and Tb gambiense) in\u00a0vitro","volume":"68","author":"R\u00e4z","year":"1997","journal-title":"Acta trop."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00436-006-0126-y","article-title":"Development of resazurin microtiter assay for drug sensibility testing of Trypanosoma cruzi epimastigotes","volume":"99","author":"Rol\u00f3n","year":"2006","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib54","first-page":"1041","article-title":"Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients","volume":"59","author":"Rousselot","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib55","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0006-2952(01)00715-8","article-title":"Effects of miltefosine on various biochemical parameters in a panel of tumor cell lines with different sensitivities","volume":"62","author":"Rybczynska","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib56","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1590\/0074-0276130496","article-title":"The in\u00a0vitro activity of fatty diamines and amino alcohols against mixed amastigote and trypomastigote Trypanosoma cruzi forms","volume":"109","author":"Sales Junior","year":"2014","journal-title":"Memorias do Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0001-706X(00)00052-8","article-title":"Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi","volume":"75","author":"Santa-Rita","year":"2000","journal-title":"Acta trop."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib58","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1128\/AAC.46.11.3472-3477.2002","article-title":"Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi","volume":"46","author":"Saraiva","year":"2002","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib59","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/AAC.48.9.3268-3271.2004","article-title":"The melaminophenyl arsenicals melarsoprol and melarsen oxide interfere with thiamine metabolism in the fission yeast Schizosaccharomyces pombe","volume":"48","author":"Schweingruber","year":"2004","journal-title":"Antimicrob. agents Chemother."},{"issue":"1","key":"10.1016\/j.ijpddr.2016.12.004_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1517\/14728220802623881","article-title":"Trypanosoma cruzi targets for new chemotherapeutic approaches","volume":"13","author":"Soeiro","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasites vectors"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib62","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4269\/ajtmh.2009.09-0015","article-title":"Development of an Alamar Blue viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427","volume":"81","author":"Sykes","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib63","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1590\/S0036-46651997000500007","article-title":"Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Parana state and from different endemic areas of Brazil","volume":"39","author":"Toledo","year":"1997","journal-title":"Rev. do Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4269\/ajtmh.2011.11-0002","article-title":"Case report: Trypanosoma lewisi or T.\u00a0lewisi-like infection in a 37-day-old indian infant","volume":"85","author":"Verma","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib65","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/AAC.00548-09","article-title":"In\u00a0vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences","volume":"53","author":"Vermeersch","year":"2009","journal-title":"Antimicrob. agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib66","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1071\/WR12115","article-title":"Importance of getting the numbers right: quantifying the rapid and substantial decline of an abundant marsupial, Bettongia penicillata","volume":"40","author":"Wayne","year":"2013","journal-title":"Wildl. Res."},{"key":"10.1016\/j.ijpddr.2016.12.004_bib67","series-title":"Sudden and Rapid Decline of the Abundant Marsupial Bettongia penicillata in Australia","first-page":"1","author":"Wayne","year":"2013"},{"key":"10.1016\/j.ijpddr.2016.12.004_bib68","doi-asserted-by":"crossref","first-page":"e3602","DOI":"10.1371\/journal.pone.0003602","article-title":"Historical mammal extinction on Christmas Island (Indian Ocean) correlates with introduced infectious disease","volume":"3","author":"Wyatt","year":"2008","journal-title":"PloS one"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716301142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716301142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:46:34Z","timestamp":1761921994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320716301142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2211320716301142"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.12.004","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In\u00a0vitro drug susceptibility of two strains of the wildlife trypanosome, Trypanosoma copemani: A comparison with Trypanosoma cruzi","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}